Article

Altered plasma membrane abundance of the sulfatide-binding protein NF155 links…

medRxiv · 2022 · McKie, S. J.; Nicholson, A. S.; Smith, E.; Fawke, S.; Caroe, E.; Williamson, J. C.; Butt, B. G.; Kolarov, D.; Peterka, O.; Holcapek, M.; Lehner, P. J.; Graham, S. C.; Deane, J. E.

Key facts

Title Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelination
First author McKie, S. J.; Nicholson, A. S.; Smith, E.; Fawke, S.; Caroe, E.; Williamson, J. C.; Butt, B. G.; Kolarov, D.; Peterka, O.; Holcapek, M.; Lehner, P. J.; Graham, S. C.; Deane, J. E.
Journal medRxiv
Published Oct 18, 2022
DOI 10.1101/2022.09.15.508082
Devices mentioned K042152, K940422, K982100
Product codes mentioned CFN, DFZ, JJQ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature